FEATURES OF THE IMMUNE RESPONSE DURING VIRAL INFECTION

Cover Page


Cite item

Full Text

Abstract

The aim of the investigation was to select using cluster analysis and comparatively characterize immune disorders types in acute and chronic viral infections. Patients with acute and chronic viral infections (n = 896) were examined: 77 patients with acute viral hepatitis B, 94 — chronic viral hepatitis B, 119 — chronic hepatitis C, 531 — recurrent herpes, 75 — human papillomavirus infection. Healthy persons (n = 466) were examined as control. The research of blood lymphocyte phenotype was performed by flow cytometry. Four-color immunophenotyping were used in the following panels: Т-lymphocytes (CD3+CD19–CD16/56–CD45+), Т-helpers (CD3+CD4+CD45+), cytotoxic Т-cells (CD3+CD8+CD45+), NKcells (CD3–CD16/56+CD45+), B-lymphocytes (CD3–CD19+CD16/56+CD45+). Absolute values were obtained on a dualplatform technology using the results of haematological analysis. The immunoglobulin concentrations were determined by ELISA. The clustering was performed by a single linkage method. The number of clusters was determined on the basis of calculating the values of the Euclidean distance between the mean group values. It was found that the parameters, characterizing the functional state of the various parts of the immune system in acute and chronic viral infections, considerable diversity values. Custer analysis allows to allocate 6 immunotypes defined different states of innate and adaptive immunity: characterized by activation of the innate (increasing the number of neutrophils and NK-cells) and adaptive immunity humoral response (increasing the concentration of IgG), characterized by hyperreaction of adaptive immunity (a significant increase in the concentration of IgG), discoordinated (multidirectional changes in the values of immunological parameters), immunodeficiency and unresponsiveness (did not differ from the control parameters) immunotypes. It is proved that in patients with viral infections most often determined by the “unresponsiveness” immunotype (40,5%), as well as humoral immunodeficiency (24,9%) and adaptive immune reaction (24,5%). A group of patients with chronic viral hepatitis B and C is allocated separately in which more than 10% of the detected adaptive immunity overreaction that is probably due to the development of chronic hepatitis. These immunotypes can be regarded as different pathogenetic variants of the course of acute and chronic viral infections. Healthy people often had unresponsiveness or immunodeficiency immunotypes, that is their immune system is out of activation. Stratification of patients with viral infections by immunotypes will increase the effectiveness of treatment and implement personalized approaches to diagnosis and treatment of functional disorders of the immune system.

About the authors

G. A. Borisov

Federal State Budgetary Scientific Research Institute of Medical Problems of the North

Author for correspondence.
Email: fake@neicon.ru
PhD (Medicine), Leading Researcher of the Laboratory of Molecular-Cell Physiology and Pathology, Krasnoyarsk Россия

A. A. Savchenko

Federal State Budgetary Scientific Research Institute of Medical Problems of the North

Email: fake@neicon.ru
PhD, MD (Medicine), Professor, Head of the Laboratory of Molecular-Cell Physiology and Pathology, Krasnoyarsk Россия

Igor V. Kudryavtsev

Research Institute of Experimental Medicine;
Far Eastern Federal University

Email: igorek1981@yandex.ru

PhD (Biology), Senior Researcher of the Laboratory of Immunology, 197376, Russian Federation, St. Petersburg, Akademika Pavlova str., 12;

Senior Researcher of the Department of Fundamental Medicine, Vladivostok

Россия

References

  1. Борисов А.Г. Кластерный анализ типов иммунных нарушений при инфекционно-воспалительных заболеваниях // Российский иммунологический журнал. 2014. Т. 8 (17), № 4. С. 1002–1011. [Borisov A.G. Cluster analysis of the types of immune disorders in infectious and inflammatory diseases. Rossiiskii immunologicheskii zhurnal = Russian Journal of Immunology, 2014, vol. 8 (17), no. 4, pp. 1002–1011. (In Russ.)]
  2. Борисов А.Г. Клиническая характеристика нарушения функции иммунной системы // Медицинская иммунология. 2013. Т. 15, № 1. С. 45–50. [Borisov A.G. Clinical characteristics of the dysfunction of the immune system. Meditsinskaya immunologiya = Medical Immunology (Russia), 2013, vol. 15, no. 1, pp. 45–50. doi: 10.15789/1563-0625-2013-1-45-50 (In Russ.)]
  3. Земсков А.М., Земсков В.М. Дополнительные методы оценки иммунного статуса // Клиническая лабораторная диагностика. 1994. № 3. С. 34–35. [Zemskov A.M., Zemskov V.M. Additional methods for assessing of the immune status. Klinicheskaya laboratornaya diagnostika = Clinical Laboratory Diagnostics, 1994, no. 3, pp. 34–35. (In Russ.)]
  4. Козлов В.А. Гомеостатическая пролиферация как основа неизбежного формирования тотального иммунодефицита // Медицинская иммунология. 2014. Т. 16, № 5. С. 403–408. [Kozlov V.A. Homeostatic proliferation as a foundation for the ine vitable formation of total immunodeficiency. Meditsinskaya immunologiya = Medical Immunology (Russia), 2014, vol. 16, no. 5, pp. 403–408. doi: 10.15789/1563-0625-2014-5-403-408 (In Russ.)]
  5. Козлов В.А., Борисов А.Г., Смирнова С.В., Савченко А.А. Практические аспекты диагностики и лечения иммунных нарушений. Новосибирск: Наука, 2009. 274 с. [Kozlov V.A., Borisov A.G., Smirnova S.V., Savchenko A.A. Prakticheskie aspekty diagnostiki i lecheniya immunnykh narushenii. [Practical aspects of diagnosis and treatment of immune disorders]. Novosibirsk: Nauka, 2009. 274 p.]
  6. Леончик Е.Ю., Савастру О.В. Кластерный анализ. Терминология, методы, задачи. Одесса: ОНУ им. И.И. Мечникова, 2007. 208 с. [Leonchik E.Yu., Savastru O.V. Klasternyi analiz. Terminologiya, metody, zadachi [Cluster analysis. Terminology, methods, exercise]. Odessa: ONU named I.I. Mechnikov, 2007, 208 p.]
  7. Нелюбин Е.В., Капулер О.М., Сибиряк С.В. Кластерный анализ показателей иммунного статуса больных псориазом // Вестник Уральской медицинской академической науки. 2006. № 3 (1). С. 76–79. [Neljubin E.V., Kapuler O.M., Sibirjak S.V.
  8. Cluster analysis of immunological parameters in patients with psoriasis. Vestnik Ural’skoj medicinskoj akademicheskoj nauki = Herald of the Ural Medical Academia, 2006, no. 3 (1), pp. 76–79. (In Russ.)]
  9. Савченко А.А., Цхай В.Б., Круглова Д.Ю., Борисов А.Г. Иммунологические показатели при моноинфекции вирусом папилломы человека и сочетанной папилломавирусной и урогенитальной инфекции // Инфекция и иммунитет. 2014. № 3. С. 241–248. [Savchenko A.A., Chaj V.B., Kruglova D.Ju., Borisov A.G. Immunological parameters in patients with monoinfection by human papillomavirus and in patients co-infected by papillomavirus and urogenital pathogens. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2014, no. 3, pp. 241–248. doi: 10.15789/2220-7619-2014-3-241-248 (In Russ.)]
  10. Саморукова Е.И., Малиничева Ю.В., Задионченко В.С., Ли В.В., Адашева Т.В., Пихлак А.Э., Логачев В.А., Соколова Л.Б. Ожирение и метаболические нарушения у больных хронической обструктивной болезнью легких: возможности фенотипирования // Пульмонология. 2014. № 5. С. 32–38. [Samorukova E.I., Malinicheva Ju.V., Zadionchenko V.S., Li V.V., Adasheva T.V., Pihlak A.Je., Logachev V.A., Sokolova L.B. Obesity and metabolic disorders in patients with chronic obstructive pulmonary disease: opportunities phenotyping. Pul’monologiya = Pulmonology, 2014, no. 5, pp. 32–38. (In Russ.)]
  11. Сарап П.В., Винник Ю.С., Останин А.А. Формирование кластеров иммунной системы и действие иммунотропных лекарственных средств у пациентов с ургентной хирургической патологией // Российский иммунологический журнал. 2012. Т. 6, № 1. С. 85–92. [Sarap P.V., Vinnik Yu.S., Ostanin A.A. Clustering effect of the immune system and immuno drugs for patients with urgent surgical pathology. Rossiiskii immunologicheskii zhurnal = Russian Journal of Immunology, 2012, vol. 6, no. 1, pp. 85–92. (In Russ.)]
  12. Хайдуков С.В., Зурочка А.В. Возможности проточной цитофлюориметрии в диагностике инфекционных заболеваний. Часть 1 // Инфекция и иммунитет. 2011. Т. 1, № 1. С. 59–66. [Hajdukov S.V., Zurochka A.V. The possibility of flow cytometry in the diagnosis of infectious diseases. Part 1. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2011, vol. 1, no. 1, pp. 59–66. doi: 10.15789/2220-7619-2011-1-59-66 (In Russ.)]
  13. Ярилин А.А. Иммунология. М.: ГЭОТАР-Медиа, 2010. 752 с. [Yarilin A.A. Immunologiya [Immunology]. Moscow: GEOTARMedia, 2010. 752 p.]
  14. Akdis C.A., Bachert C., Cingi C., Dykewicz M.S., Hellings P.W., Naclerio R.M., Schleimer R.P., Ledford D. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol., 2013, vol. 131, pp. 1479–1490. doi: 10.1016/j. jaci.2013.02.036
  15. Braciale T.J., Hahn Y.S. Immunity to viruses. Immunol Rev., 2013, vol. 255, no. 1, pp. 5–12. doi: 10.1111/imr.12109
  16. Campo P., Rodríguez F., Sánchez-García S., Barranco P., Quirce S., Pérez-Francés C., Gómez-Torrijos E., Cárdenas R., Olaguibel J.M., Delgado J. Severe Asthma Workgroup; SEAIC Asthma Committee. Phenotypes and endotypes of uncontrolled severe asthma: new treatments. J. Investig. Allergol. Clin. Immunol., 2013, vol. 23, pp. 76–88.
  17. Cui Y., Yang X., Zhu W., Li J., Wu X., Pang Y. Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients. Oncol. Lett., 2013, vol. 6, pp. 537–541. doi: 10.3892/ol.2013.1376
  18. Faner R., Cruz T., Agusti A. Immune response in chronic obstructive pulmonary disease. Expert Rev. Clin. Immunol., 2013, vol. 9, pp. 821–833. doi: 10.1586/1744666X.2013.828875
  19. Karim R., Mack W.J., Stiller T., Operskalski E., Frederick T., Landay A., Young M.A., Tien P.C., Augenbraun M., Strickler H.D., Kovacs A. Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS, 2013, vol. 27, pp. 1473–1481. doi: 10.1097/QAD.0b013e3283601bad
  20. Lin T.Y., Poon A.H., Hamid Q. Asthma phenotypes and endotypes. Curr. Opin. Pulm. Med., 2013, vol. 19, pp. 18–23. doi: 10.1097/MCP.0b013e32835b10ec
  21. Lindsay C.R., Shaw E., Walker I., Johnson P.W. Lessons for molecular diagnostics in oncology from the Cancer Research UK Stratified Medicine Programme. Expert Rev. Mol. Diagn., 2014, vol. 30, pp. 1–3. doi: 10.1586/14737159.2015.992417
  22. Lötvall J., Akdis C.A., Bacharier L.B., Bjermer L., Casale T.B., Custovic A., Lemanske R.F.Jr., Wardlaw A.J., Wenzel S.E., Greenberger P.A. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol., 2011, vol. 127, no. 2, pp. 355–360. doi: 10.1016/j.jaci.2010.11.037
  23. Luider J.L., Cyfra M., Johnson P., Auer I. Impact of the new Beckman Coulter Cytomics FC 500 5-color flow cytometer on a regional flow cytometry clinical laboratory service. Lab. Hematol., 2004, vol. 10, pp. 102–108.
  24. Maecker H., McCoy P., Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat. Rev. Immunol., 2012, vol. 12, pp. 191–200. doi: 10.1038/nri3158
  25. McLernon D.J., Te Velde E.R., Steyerberg E.W., Mol B.W., Bhattacharya S. Clinical prediction models to inform individualized decision-making in subfertile couples: a stratified medicine approach. Hum. Reprod., 2014, vol. 29, no. 9, pp. 1851–1858. doi: 10.1093/humrep/deu173
  26. Medzhitov R., Schneider D.S., Soares M.P. Disease tolerance as a defense strategy. Science, 2012, vol. 335, no. 6071, pp. 936–941. doi: 10.1126/science.1214935
  27. O’Neil S.E., Lundbäck B., Lötvall J. Serena E. Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities. J. Proteomics, 2011, vol. 75, no. 1, pp. 192–201. doi: 10.1016/j.jprot.2011.10.008
  28. Soares M.P., Gozzelino R., Weis S. Tissue damage control in disease tolerance. Trends Immunol., 2014, vol. 35, no. 10, pp. 483–494. doi: 10.1016/j.it.2014.08.001
  29. Trusheim M.R., Berndt E.R., Douglas F.L. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat. Rev. Drug Discov., 2007, vol. 6, no. 4, pp. 287–293. doi: 10.1038/nrd2251

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Borisov G.A., Savchenko A.A., Kudryavtsev I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies